Susan Hasty, Publisher
Table of Contents . . . March 30th, 1998Non-Subscriber - Summaries Only
Prostate Cancer - Immunotherapy and Gene Therapy Used against Prostate Cancer
Cancer Gene Therapy - bax Overexpression Induces Apoptosis in Breast Cancer Cells
Cancer Gene Therapy - Adenovirus-Mediated Gene Therapy Looks Promising against Thyroid Cancer
Cancer Gene Therapy - Two Strategies Against Pancreatic Cancer Explored at Conference
Cancer Immunotherapy - p53 Stimulated Cytotoxic T Cells Target Bladder Cancer In Vivo
Cancer Immunotherapy - IL-2 Successfully Incorporated in Immuno-Gene Therapy Strategies
Cancer Gene Therapies - Agreement To License MDA-7 Tumor Suppressor Gene Announced
Genetics - Dog Blindness Has Genetic Link to Human Form
Industry News (Joint Venture) - European Collaboration Formed for Tissue Regeneration Research
Industry News (Joint Venture) - HIV Partnership Formed To Develop HIV Managed Care Initiatives
Industry News (Patents and Technologies) - Method Patent for Oncology Treatment Allowed
Pathogenesis - Research Shows Anti-AIDS Cell Vulnerable to HIV
Risk Factors - Hormonal Milk Poses Prostate Cancer and Other Cancers Risks
Sickle Cell Disease - Pivotal Phase III FLOCOR Trial for Disease Treatment Begins
Xenotransplantation - Group Said Xenotransplants Could Lead To New AIDS
Cancer Vaccines - "Genetic Immunization Against Mutant P53."
Cancer Gene Therapy - "Cancer Gene Therapy with a Heat Shock Protein Gene."
HIV Gene Therapy - "Polymeric TAR-RRE RNA Decoys as Candidates for HIV-1 Gene Therapy."
Adenosine Deaminase Deficiency - "Visible Integration of the Adenosine Deaminase (ADA) Gene into the Recipient Genome after Gene Therapy."
Cancer Gene Therapy - "Superiority of Interleukin-12-Transduced Murine Lung Cancer Cells to GM-CSF or B7-1 (CD80) Transfectants for Therapeutic Antitumor Immunity in Syngeneic Immunocompetent Mice. DOUBLEQUO
Cancer Gene Therapy - "p53 Tumor Suppressor Gene Therapy for Cancer."
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.